Cita APA (7a ed.)

Ramos, P. M., Giraldo, Y. G., Álvarez-Chiva, V., Arroyo, D., Merino, C. S., Francés, F. M., . . . Quiroga, B. (2021). Proteinuria-Lowering Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Chronic Kidney Disease Patients: A Real-World Multicentric Study. MDPI AG.

Cita Chicago Style (17a ed.)

Ramos, Patricia Muñoz, et al. Proteinuria-Lowering Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Chronic Kidney Disease Patients: A Real-World Multicentric Study. MDPI AG, 2021.

Cita MLA (8a ed.)

Ramos, Patricia Muñoz, et al. Proteinuria-Lowering Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Chronic Kidney Disease Patients: A Real-World Multicentric Study. MDPI AG, 2021.